As a consequence, it maintains the intestinal barrier integrity, reduces the translocation of intestinal-derived LPS, and inhibits the liver LPS/TLR4 signaling pathway to improve hepatic steatosis and steatohepatitis (Figure 7). The gene discussed is TLR4; the disease is Hepatic steatosis.